Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Simvastatin reduces venous stenosis formation in a murine hemodialysis vascular access model.

Janardhanan R, Yang B, Vohra P, Roy B, Withers S, Bhattacharya S, Mandrekar J, Kong H, Leof EB, Mukhopadhyay D, Misra S.

Kidney Int. 2013 Aug;84(2):338-52. doi: 10.1038/ki.2013.112. Epub 2013 May 1.

2.

Adventitial transduction of lentivirus-shRNA-VEGF-A in arteriovenous fistula reduces venous stenosis formation.

Yang B, Janardhanan R, Vohra P, Greene EL, Bhattacharya S, Withers S, Roy B, Nieves Torres EC, Mandrekar J, Leof EB, Mukhopadhyay D, Misra S.

Kidney Int. 2014 Feb;85(2):289-306. doi: 10.1038/ki.2013.290. Epub 2013 Aug 7.

3.

The Role of Repeat Administration of Adventitial Delivery of Lentivirus-shRNA-Vegf-A in Arteriovenous Fistula to Prevent Venous Stenosis Formation.

Janardhanan R, Yang B, Kilari S, Leof EB, Mukhopadhyay D, Misra S.

J Vasc Interv Radiol. 2016 Apr;27(4):576-83. doi: 10.1016/j.jvir.2015.12.751. Epub 2016 Mar 2.

4.

Increased expression of HIF-1alpha, VEGF-A and its receptors, MMP-2, TIMP-1, and ADAMTS-1 at the venous stenosis of arteriovenous fistula in a mouse model with renal insufficiency.

Misra S, Shergill U, Yang B, Janardhanan R, Misra KD.

J Vasc Interv Radiol. 2010 Aug;21(8):1255-61. doi: 10.1016/j.jvir.2010.02.043. Epub 2010 Jul 3.

5.

Increased shear stress with upregulation of VEGF-A and its receptors and MMP-2, MMP-9, and TIMP-1 in venous stenosis of hemodialysis grafts.

Misra S, Fu AA, Puggioni A, Karimi KM, Mandrekar JN, Glockner JF, Juncos LA, Anwer B, McGuire AM, Mukhopadhyay D.

Am J Physiol Heart Circ Physiol. 2008 May;294(5):H2219-30. doi: 10.1152/ajpheart.00650.2007. Epub 2008 Mar 7.

6.

The role of Iex-1 in the pathogenesis of venous neointimal hyperplasia associated with hemodialysis arteriovenous fistula.

Brahmbhatt A, NievesTorres E, Yang B, Edwards WD, Roy Chaudhury P, Lee MK, Kong H, Mukhopadhyay D, Kumar R, Misra S.

PLoS One. 2014 Jul 18;9(7):e102542. doi: 10.1371/journal.pone.0102542. eCollection 2014.

8.

Prevention of Venous Neointimal Hyperplasia by a Multitarget Receptor Tyrosine Kinase Inhibitor.

Kwon SH, Li L, He Y, Tey CS, Li H, Zhuplatov I, Kim SJ, Terry CM, Blumenthal DK, Shiu YT, Cheung AK.

J Vasc Res. 2015;52(4):244-256. doi: 10.1159/000442977. Epub 2016 Jan 21.

9.

Adventitial delivery of lentivirus-shRNA-ADAMTS-1 reduces venous stenosis formation in arteriovenous fistula.

Nieves Torres EC, Yang B, Roy B, Janardhanan R, Brahmbhatt A, Leof E, Mukhopadhyay D, Misra S.

PLoS One. 2014 Apr 14;9(4):e94510. doi: 10.1371/journal.pone.0094510. eCollection 2014. Erratum in: PLoS One. 2014;9(11):e113312. Roy, Bhaskar [added].

10.

Adventitial endothelial implants reduce matrix metalloproteinase-2 expression and increase luminal diameter in porcine arteriovenous grafts.

Nugent HM, Sjin RT, White D, Milton LG, Manson RJ, Lawson JH, Edelman ER.

J Vasc Surg. 2007 Sep;46(3):548-556.

11.

The possible effect of colchicine on arteriovenous fistula maturation via neointimal hyperplasia blockage.

Eroglu E, Kocyigit I.

Kidney Int. 2014 Aug;86(2):446. doi: 10.1038/ki.2014.134. No abstract available.

PMID:
25079025
12.

Simvastatin attenuates pulmonary vascular remodelling by down-regulating matrix metalloproteinase-1 and -9 expression in a carotid artery-jugular vein shunt pulmonary hypertension model in rats.

Yao J, Xiong M, Tang B, Chen G, Liang M, Ma X, Wang Z, Wu Z.

Eur J Cardiothorac Surg. 2012 Nov;42(5):e121-7. doi: 10.1093/ejcts/ezs445.

PMID:
23087098
13.

Adventitial transplantation of blood outgrowth endothelial cells in porcine haemodialysis grafts alleviates hypoxia and decreases neointimal proliferation through a matrix metalloproteinase-9-mediated pathway--a pilot study.

Hughes D, Fu AA, Puggioni A, Glockner JF, Anwer B, McGuire AM, Mukhopadhyay D, Misra S.

Nephrol Dial Transplant. 2009 Jan;24(1):85-96. doi: 10.1093/ndt/gfn433. Epub 2008 Sep 11.

14.

Tissue Factor Activity in Dialysis Access Grafts.

Hasenstab D, Kirkman TR, Clowes AW, Kohler TR.

Ann Vasc Surg. 2016 Feb;31:179-85. doi: 10.1016/j.avsg.2015.10.008. Epub 2015 Nov 17.

PMID:
26597243
15.

The authors reply.

Janardhanan R, Misra S.

Kidney Int. 2014 Aug;86(2):446. doi: 10.1038/ki.2014.137. No abstract available.

16.
17.

Paclitaxel coating of the luminal surface of hemodialysis grafts with effective suppression of neointimal hyperplasia.

Baek I, Bai CZ, Hwang J, Nam HY, Park JS, Kim DJ.

J Vasc Surg. 2012 Mar;55(3):806-814.e1. doi: 10.1016/j.jvs.2011.09.012. Epub 2012 Jan 5.

18.

Myofibroblasts: the ideal target to prevent arteriovenous fistula failure?

Duque JC, Vazquez-Padron RI.

Kidney Int. 2014 Feb;85(2):234-6. doi: 10.1038/ki.2013.384.

PMID:
24487362
19.

Expression of hypoxia inducible factor-1 alpha, macrophage migration inhibition factor, matrix metalloproteinase-2 and -9, and their inhibitors in hemodialysis grafts and arteriovenous fistulas.

Misra S, Fu AA, Rajan DK, Juncos LA, McKusick MA, Bjarnason H, Mukhopadhyay D.

J Vasc Interv Radiol. 2008 Feb;19(2 Pt 1):252-9. doi: 10.1016/j.jvir.2007.10.031.

PMID:
18341958
20.

Blood outgrowth endothelial cells reduce hypoxia-mediated fibroblast to myofibroblast conversion by decreasing proangiogenic cytokines.

Nieves Torres EC, Yang B, Brahmbhatt A, Mukhopadhyay D, Misra S.

J Vasc Res. 2014;51(6):458-67. doi: 10.1159/000369929. Epub 2015 Feb 7.

Supplemental Content

Support Center